Birkenstock Growth Story Intact but Valuation Keeps Us on Sidelines

What happened

Birkenstock is delivering strong revenue growth of 13-15% this year, with management targeting 10% pair growth and signaling undervaluation through a $250M buyback. However, the stock still trades at ~24x EPS and ~17x EV/EBITDA, well above a conservative DCF estimate, suggesting high expectations are already priced in. Risks from U.S. tariffs on EU goods, weak design IP protection, and persistent internal control weaknesses reduce the margin of safety. The DeepValue report maintains a 'Wait' stance, seeing the stock as a solid business but not a bargain at current levels. The bullish article does not change that calculus; execution and de-risking are needed to justify a more constructive view.

Implication

For long-term investors, Birkenstock's brand strength and growth trajectory are compelling, but the current valuation offers limited upside relative to the risks. If the stock pulls back to a more conservative multiple (e.g., mid-teens P/E) or if management delivers sustained margin expansion and resolves control weaknesses, the stock could become a buy. Near-term, the buyback provides some support, but it is small relative to market cap and does not address structural risk. Given the DeepValue report's caution, we prefer to wait for a better entry point or clearer evidence of de-risking. A disciplined investor should require a larger margin of safety before committing capital.

Thesis delta

The bullish narrative from the Seeking Alpha article reinforces the positive underlying fundamentals, but does not alter the 'Wait' stance from the DeepValue report. The key risk remains that the stock's premium valuation already reflects strong growth, leaving little room for error. The thesis shifts slightly from 'Wait for better valuation' to 'Wait for better valuation or clear de-risking' – essentially unchanged, but with a slightly more positive tilt on fundamentals.